Uncommon Curess, LLC Is Please To Announce That Dr. Tam Roshan Lal Has Joined The Company As Chief Medical Officer.
For Immediate Release Uncommon Cures, LLC is pleased to announce that Dr. Tam Roshan Lal has joined the company as Chief Medical Officer. Dr. Roshan Lal is an experienced rare disease clinician with extensive clinical trials experience. Prior to joining Uncommon Cure, she worked as an Attending Metabolic Geneticist at the Rare Disease Institute (RDI), Childrens National […]
Uncommon Cures, LLC Begins Operations With Series A Funding To Bring Cost-Effective And Time-Efficient Clinical Trials To The Rare Disease Field.
Uncommon Cures, LLC, a privately held rare disease clinical research organization (CRO), begins operations after completing its Series A financing led by PilotRock Investments, LLC. Uncommon Cures brings together a team of rare disease physicians with over 75 years of combined experience and a deeply experienced clinical trials team. Uncommon Cures’ mission is to reduce […]
